RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Innovatus Capital Partners
I

Innovatus Capital Partners portfolio

Innovatus Capital Partners has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Geneoscopy's $105M Series B+ round in November 2021, alongside NT Investments, Morningside, Lightchain and 3 others. By category, its portfolio leans toward Health and bio (2) and Data and analytics (1). It has co-invested with NT Investments, Morningside and LabCorp.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $205M.
Latest deal: Geneoscopy · Nov 16, 2021.

What Innovatus Capital Partners invests in

How Innovatus Capital Partners invests

StageDealsCapital in rounds
Series B+ 2 100%$205M

Share is of the 2 rounds on Recent Funding that name Innovatus Capital Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Innovatus Capital Partners portfolio companies

CompanyRound with Innovatus Capital PartnersTotal raisedLatest raise
GGeneoscopy
Health and bio
Series B+ · $105M$216.9MJan 8, 2025
Series B+
PPersonal Genome Diagnostics
Health and bio
Series B+ · $100M$123.8MNov 24, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Innovatus Capital Partners, which is a subset of its real portfolio. API: /api/v1/investors/innovatus-capital-partners (get a free API key). More: the most active VC firms and new venture capital funds.